FDA Issues Final Guidance to Boost Development of Cell-based Viral Vaccines
posted on 3 March 2010 | posted in Flu Pandemic
|The U.S. Food and Drug Administration today issued final guidance to help manufacturers who are developing safe and effective cell-based viral vaccines to address emerging and pandemic threats.|
Full Article >>>
|You can follow other blog entries via the RSS feed.
You can also leave your own response. Site administrator reserves the right to reject any replies that are deemed inappropriate.